Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CDK4 Inhibitor by BeiGene for Breast Cancer: Likelihood of Approval
CDK4 Inhibitor is under clinical development by BeiGene and currently in Phase I for Breast Cancer. According to GlobalData, Phase...